OF THE DISCLSOURE This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, 5 preferably in combination with one or more additional anti-tumor therapeutic agents. 10728141_1 (GHMatters) P87074.AU.3